A Phase I Study of PTM-101 as Neoadjuvant Therapy for Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

Pilgrim, Charles (Primary Chief Investigator (PCI))
Nikfarjam, Mehrdad (Chief Investigator (CI))
Hawkins, Cheryl-Ann (Project Manager)

Surgery Alfred Hospital

Project: Research

Status	Active
Effective start/end date	6/08/21 → 31/12/24

Keywords

Pancreatic Ductal Adenocarcinoma (PDAC)
Gastroenterology
Pancreatic cancer
Clinical trial